- GSK announces divestment of OTC brands
- CRN to host free webinar on supplement regs for Pharmacist Society
- Prestige Brands completes remainder of GSK OTC brands acquisition
- GSK shares real-world example on how to improve switch through technology
- Survey: Supplement users make healthier lifestyle choices
WASHINGTON — Members of the Consumer Healthcare Products Association last week elected Paul Sturman, president and general manager of Pfizer Consumer Healthcare, to chair the association’s board, the association announced Monday.
“I’m honored to take on this new role and work closely with the board, our allies and Capitol Hill to promote the importance of [over-the-counter] medicines and dietary supplements in the healthcare continuum,” Sturman said. “Shaping policies that continue to provide self-care solutions and cost-effective options is a top priority.”
“As our nation seeks cost-effective healthcare options, CHPA is committed to demonstrating the role, value and accessibility that over-the-counter medicines and dietary supplements provide in our healthcare delivery system,” stated Scott Melville, CHPA president and CEO. “Paul is a thoughtful and experienced industry leader who brings a keen strategic vision to the association, and a commitment to strong board governance and oversight.”
In addition to Sturman, the CHPA welcomed the following to its board: Chris Combe, Combe Inc. chairman; Colin Mackenzie, president of GlaxoSmithKline North America Consumer Healthcare; Daren Mazzucca, publisher of Meredith’s Midwest Living; Dennis O’Donnell, Matrixx Initiatives president and CEO; Paul Scoggins, Johnson & Johnson/Merck Consumer Pharmaceuticals general manager; David Wendland, VP Hamacher Resource Group; and Steven Woolf, EVP and CFO of Humco.
Sturman becomes CHPA’s 54th chair and succeeds Christopher DeWolf of Lil’ Drug Store Products. He earned his bachelor’s degree in biology and his master’s degree in business administration from Bucknell University.